In ESCC research, FOXO1 can be acetylated, which increases its binding at the IL7R promoter, suppresses IL7R transcription, and inhibits the tumorigenic role of the IL7R [57]. This evidence concerns the gene FOXO1 and esophageal squamous cell carcinoma.